Vaccine and Pharmaceutical Technologies

Improving vaccine and pharmaceutical products and impact in developing countries

Our work in vaccine and pharmaceutical technologies extends across three interrelated technical portfolios with more than 30 years of experience in product formulation and stabilization, delivery devices, and supply systems and equipment for low-resource settings. Learn more »

Protecting Kids: powerful stories of immunization from the field

Protecting kids

Meet the people on the ground who are passionate about making sure kids get the vaccines they need. Don’t miss Protecting Kids, a collection of stories curated from friends and partners of PATH about how vaccination can help give children and families that chance. See the curated blog site »

News and highlights

BLOG: PATH’s Changcheng Zhu shares his personal experience with polio and how his mother’s love and determination motivates his daily work »

REPORT: An updated generic Preferred Product Profile for Vaccines offers manufacturers key recommendations in four domains: formulation, presentation, labelling, and packaging »

NEWS: PBS NewsHour profiles PATH’s work on the Uniject injection system, vaccine vial monitor, and fast-dissolving vaccine tablets »

ARTICLE: Using a  thermoresponsive gel to achieve sublingual immunization in mice »

Sign up for our e-newsletter

Sign up for our e-newsletter.The e-newsletter, Vaccine and Pharmaceutical Technologies News and Updates, provides semiannual briefings and related resources on our work to advance technologies that improve vaccine and pharmaceutical products and the way they are delivered, especially in low-resource settings. Sign up now »

Visit the Vaccine Resource Library

PATH’s Vaccine Resource Library (VRL) contains key immunization resources in a single, easy-to-use website. The VRL offers links to scientific publications and high-quality, technical summaries on specific diseases and topics in immunization. To learn more, visit the VRL »

Banner photos, clockwise from left: PATH/Patrick McKern; PATH/Gabe Bienczycki; PATH/Mike Wang.

Comments are closed.